Skip to content
mapperlab
← Dashboard
Stock

DNA

GINKGO BIOWORKS HOLDINGS, INC.
Latest close $7.376 of 27 marquee funds currently hold2 CUSIPs mapped
Current holders
6
27 funds tracked
Ever held
12
Current + past
New this quarter
1
Exited this quarter
2

Marquee-fund ownership over time

Nov 15, 2021May 15, 2024May 14, 2025May 15, 2026
Now
6

This quarter's activity

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Viking Global Investors re-entered$0.00$7.37
Renaissance Technologies re-entered$0.00
Two Sigma Investments re-entered$0.00$7.37
D.E. Shaw re-entered$0.00$7.37
AQR Capital Management re-entered$0.00$7.37
Millennium Management re-entered$0.00$7.37

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Glenview Capital 2× in & out→ $7.71+5%
Point72 Asset Management 2× in & out→ $7.71-14%
Citadel Advisors 2× in & out→ $8.03-38%
Coatue Management+0%
Bridgewater Associates+0%
Tiger Global+0%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at Ginkgo Bioworks Holdings, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
1
Filings · last 90d
9
Total on file
202
Recent SEC buffer
Most recent
May 26, 2026

30d / 90d windows measured from May 26, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 202 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · GINKGO BIOWORKS HOLDINGS, INC.

Annual figures sourced directly from GINKGO BIOWORKS HOLDINGS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$170.16M
FY2025-25% YoY
Net income
-$312.76M
FY2025+43% YoY
EPS (diluted)
$-5.64
FY2025+46% YoY
Free cash flow(?)
-$178.72M
FY2025+53% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Ginkgo Bioworks Holdings, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Renaissance TechnologiesQ2 2026open$7.85$7.37-6%
D.E. ShawQ1 2026open$9.00$7.37-18%
Point72 Asset ManagementQ1 2026Q2 2026$9.00$7.71-14%
Citadel AdvisorsQ3 2025Q4 2025$13$8.03-38%
D.E. ShawQ3 2025Q4 2025$13$8.03-38%
Citadel AdvisorsQ1 2025Q2 2025$15$7.67-48%
Point72 Asset ManagementQ1 2025Q3 2025$15$13-12%
Two Sigma InvestmentsQ4 2024open$7.31$7.37+1%
Viking Global InvestorsQ4 2024open$7.31$8.94+22%
Glenview CapitalQ4 2024Q2 2026$7.31$7.71+5%
D.E. ShawQ4 2024Q2 2025$7.31$7.67+5%
AQR Capital ManagementQ4 2024open$7.31$7.37+1%
Millennium ManagementQ4 2024open$7.31$7.37+1%
Renaissance TechnologiesQ4 2024Q2 2025$8.60$7.83-9%
Two Sigma InvestmentsQ3 2024Q4 2024$0.00+0%
D.E. ShawQ3 2024Q4 2024$0.00+0%
AQR Capital ManagementQ3 2024Q4 2024$0.00+0%
Millennium ManagementQ3 2024Q4 2024$0.00+0%
Renaissance TechnologiesQ3 2024Q4 2024$0.00+0%
Glenview CapitalQ2 2024Q4 2024$0.00+0%
Coatue ManagementQ3 2022Q4 2022$0.00+0%
Bridgewater AssociatesQ3 2022Q4 2022$0.00+0%
Tiger GlobalQ4 2021Q2 2022$0.00+0%
Viking Global InvestorsQ4 2021Q4 2024$0.00+0%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.